1-2 of 2
Albert Oriol Rocafiguera, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Phase 1 Results of Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Alfred L. Garfall, MD, Saad Z. Usmani, MDMBBS,MBA, María-Victoria Mateos, Hareth Nahi, MD PhD, Niels W.C.J. van de Donk, MD PhD, Jesus F. San-Miguel, MD PhD, Albert Oriol Rocafiguera, MD, Laura Rosinol, MD PhD, Ajai Chari, MD, Manisha Bhutani, MD, Lixia Pei, PhD, Raluca Verona, PhD, Suzette Girgis, PhD BPharm, MS, Tara Stephenson, PhD, Jenna D. Goldberg, MD, Arnob Banerjee, MD, Amrita Krishnan, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27.
https://doi.org/10.1182/blood-2020-138831
Published: 2020
Journal Articles

Phase II Optimization, Open-Label Clinical Trial of Zalypsis ® (PM00104) in Relapsed/Refractory Multiple Myeloma Patients

Enrique M Ocio, MD, PhD, Javier De La Rubia, MD, Albert Oriol-Rocafiguera, MD, Joan Blade, MD, Jose Rodriguez, MD, Cinthya Coronado, MD, Jesus Martin Sanchez, MD, Ana Isabel Teruel, MD, Dolores Hernandez-Maraver, MD, Felipe Prosper, MD, Jesus. F San-Miguel, MD
Journal: Blood
Blood (2012) 120 (21): 4041.
https://doi.org/10.1182/blood.V120.21.4041.4041
Published: 2012